A lo largo de la celebración del Congreso de la American Heart Association 2013 (Dallas, del 16 al 20 de noviembre) se comentará en el blog de Revista Española de Cardiología los Late-Breaking Clinical Trials.
En concreto, se centrará en las sesiones que se enumeran más abajo
El programa de ambas sesiones será retransmitido en directo desde el congreso AHA
18 y 19 de Noviembre de 2013 a las 14:00h.
DOMINGO, 17 NOVIEMBRE 2013/ SUNDAY, NOV. 17, 2013
LBCT 1: Acute Cardiovascular and Cerebrovascular Care
Nitrites in Acute Myocardial Infarction: NIAMI.
Blood Pressure Reduction Among Acute Ischemic Stroke Patients: A Randomized Controlled Clinical Trial.
Randomized Clinical Trial of Pre-hospital Induction of Mild Hypothermia in Out-of-hospital Cardiac Arrest Patients Using a Rapid Infusion Normal Saline.
Target Temperature Management 33°C Versus 36°C After Out-of-hospital Cardiac Arrest, a Randomized, Parallel Group, Assessor Blinded Clinical Trial.
LUNES, 18 NOVIEMBRE 2013/MONDAY, NOV. 18, 2013
LBCT 2: Prevention: From Schools to Countries
Promotion of Cardiovascular Health in Preschool Children: 36-month Cohort Follow-up.
Randomized Trial of Social Network Lifestyle Intervention for Obesity: MICROCLINIC Intervention Results and 16-Month Follow-up.
Multifaceted Intervention to Improve Medication Adherence and Secondary Prevention Measures (Medication Study) After Acute Coronary Syndrome Hospital Discharge.
China Rural Health Initiative - Sodium Reduction Study: the Effects of a Community-based Sodium Reduction Program on 24hr Urinary Sodium and Blood Pressure in Rural China.
LBCT 3: Medical and Surgical Approaches to Improving Heart Failure Outcomes
Atrial Antitachycardia Pacing and Managed Ventricular Pacing Reduce the Endpoint Composed by Death, Cardiovascular Hospitalizations and Permanent Atrial Fibrillation Compared to Conventional Dual Chamber Pacing in Bradycardia Patients: Results of the Minerva Randomized Study.
Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial. Severe Ischemic Mitral Regurgitation: Is it Better to Repair or Replace the Valve? The CTSN SMR trial.
Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT).
LBCT 4: Therapeutic Advances in Coronary and Peripheral Vascular Disease
One Year Mortality in STEMI Patients Randomized to Primary PCI or a Pharmaco-invasive Strategy. The Stream 1 Year Follow-up.
Secretory Phospholipase A2 Inhibition with Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome: Results of the VISTA-16 Study.
Randomized Comparison of Endovascular Revascularization Plus Supervised Exercise Therapy Versus Supervised Exercise Therapy Only in Patients with Peripheral Artery Disease and Intermittent Claudication: Results of the Endovascular Revascularization and Supervised Exercise (ERASE) Trial.
A Randomized Multicenter Clinical Trial of Renal Artery Stenting in Preventing Cardiovascular and Renal Events: Results of the CORAL Study.
MARTES, 19 de NOVIEMBRE 2013/TUESDAY, NOV. 19, 2013
LBCT 5: New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis
RADAR-AF Trial. A Randomized Multicenter Comparison of Radiofrequency Catheter Ablation of Drivers versus Circumferential Pulmonary Vein Isolation in Patients with Atrial Fibrillation.
A Randomized Trial Comparing Genotype-guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study. The Clarification of Optimal Anticoagulation Through Genetics (COAG) Trial.
ENGAGE AF-TIMI 48 Primary Results.
https://www.secardiologia.es/aha13.html
En concreto, se centrará en las sesiones que se enumeran más abajo
El programa de ambas sesiones será retransmitido en directo desde el congreso AHA
18 y 19 de Noviembre de 2013 a las 14:00h.
- Dr. Leopoldo Pérez de Isla. Hospital Clínico de San Carlos, Madrid
Se realizarán dos conexiones, para facilitar la máxima participación.
Jueves 21 de Noviembre de 2013
14:00 Sesión 1
19:00 Sesión 2
14:00 Sesión 1
19:00 Sesión 2
DOMINGO, 17 NOVIEMBRE 2013/ SUNDAY, NOV. 17, 2013
LBCT 1: Acute Cardiovascular and Cerebrovascular Care
Nitrites in Acute Myocardial Infarction: NIAMI.
Blood Pressure Reduction Among Acute Ischemic Stroke Patients: A Randomized Controlled Clinical Trial.
Randomized Clinical Trial of Pre-hospital Induction of Mild Hypothermia in Out-of-hospital Cardiac Arrest Patients Using a Rapid Infusion Normal Saline.
Target Temperature Management 33°C Versus 36°C After Out-of-hospital Cardiac Arrest, a Randomized, Parallel Group, Assessor Blinded Clinical Trial.
LUNES, 18 NOVIEMBRE 2013/MONDAY, NOV. 18, 2013
LBCT 2: Prevention: From Schools to Countries
Promotion of Cardiovascular Health in Preschool Children: 36-month Cohort Follow-up.
Randomized Trial of Social Network Lifestyle Intervention for Obesity: MICROCLINIC Intervention Results and 16-Month Follow-up.
Multifaceted Intervention to Improve Medication Adherence and Secondary Prevention Measures (Medication Study) After Acute Coronary Syndrome Hospital Discharge.
China Rural Health Initiative - Sodium Reduction Study: the Effects of a Community-based Sodium Reduction Program on 24hr Urinary Sodium and Blood Pressure in Rural China.
LBCT 3: Medical and Surgical Approaches to Improving Heart Failure Outcomes
Atrial Antitachycardia Pacing and Managed Ventricular Pacing Reduce the Endpoint Composed by Death, Cardiovascular Hospitalizations and Permanent Atrial Fibrillation Compared to Conventional Dual Chamber Pacing in Bradycardia Patients: Results of the Minerva Randomized Study.
Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial. Severe Ischemic Mitral Regurgitation: Is it Better to Repair or Replace the Valve? The CTSN SMR trial.
Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT).
LBCT 4: Therapeutic Advances in Coronary and Peripheral Vascular Disease
One Year Mortality in STEMI Patients Randomized to Primary PCI or a Pharmaco-invasive Strategy. The Stream 1 Year Follow-up.
Secretory Phospholipase A2 Inhibition with Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome: Results of the VISTA-16 Study.
Randomized Comparison of Endovascular Revascularization Plus Supervised Exercise Therapy Versus Supervised Exercise Therapy Only in Patients with Peripheral Artery Disease and Intermittent Claudication: Results of the Endovascular Revascularization and Supervised Exercise (ERASE) Trial.
A Randomized Multicenter Clinical Trial of Renal Artery Stenting in Preventing Cardiovascular and Renal Events: Results of the CORAL Study.
MARTES, 19 de NOVIEMBRE 2013/TUESDAY, NOV. 19, 2013
LBCT 5: New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis
RADAR-AF Trial. A Randomized Multicenter Comparison of Radiofrequency Catheter Ablation of Drivers versus Circumferential Pulmonary Vein Isolation in Patients with Atrial Fibrillation.
A Randomized Trial Comparing Genotype-guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study. The Clarification of Optimal Anticoagulation Through Genetics (COAG) Trial.
ENGAGE AF-TIMI 48 Primary Results.
https://www.secardiologia.es/aha13.html
